A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis

Inclusion Criteria

• •Diagnosis of plaque psoriasis (PsO) for ≥ 6 months
• •Body mass index 18 to 40 kg/m\^2 and total body weight \> 50 kg (110 lbs)
• •Deemed by Investigator to be eligible for phototherapy or systemic therapy
• •Psoriatic plaques must cover ≥ 10% of body surface area at baseline
• •Psoriasis Area and Severity Index (PASI) score ≥ 12 and static Physician Global Assessment (sPGA) ≥ 3 at baseline